Ohmyhome (OMH) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
13 Jun, 2025Executive summary
Revenue for 1H 2024 reached S$4.5 million (US$3.3 million), up 106% year-over-year, driven by growth across all business units.
Net loss narrowed to S$2.3 million (US$1.7 million), with loss per diluted share improving to US$(0.07).
Gross profit increased 108% year-over-year, with margin improvements in all segments.
Cash and cash equivalents rose to S$2.4 million (US$1.8 million) as of June 30, 2024.
CEO highlighted operational improvements and confidence in continued growth.
Financial highlights
Brokerage services revenue grew 13.9% year-over-year despite market headwinds.
Property management contributed S$2.0 million in new revenue.
Emerging and other services revenue rose 16%, with third-party revenue up 206%.
Gross margin for brokerage services increased from 46% to 49%; property management at 33%; emerging and other services from 23% to 28%.
EBITDA loss margin improved from -107% to -44%; EBITDA loss reduced by 15% to S$2.0 million.
Outlook and guidance
Management anticipates further EBITDA loss reduction in 2H 2024, supported by higher contract values and ongoing cost optimization.
Additional business growth updates expected after Q3 2024.
Latest events from Ohmyhome
- Strong growth, improved margins, and cash flow signal a path to near-term profitability.OMH
Q3 202418 Jan 2026 - Revenue up 49% with margin improvement; cash reserves strengthened amid ongoing net loss.OMH
H1 20259 Jan 2026 - Property tech firm targets $300M shelf offering amid growth plans and Nasdaq compliance risks.OMH
Registration Filing16 Dec 2025 - Flexible $300M shelf registration targets growth amid operational and Nasdaq compliance risks.OMH
Registration Filing16 Dec 2025 - Proptech firm seeks $300M to fund growth amid going concern and Nasdaq compliance risks.OMH
Registration Filing16 Dec 2025 - Revenue up 118% and net loss narrowed, with strong growth in all business segments.OMH
H2 202416 Jun 2025